Latest
Morgan Stanley lifts semiconductor equipment outlook on stronger DRAM demand
Analysts raise 2026 and 2027 wafer fabrication equipment forecasts as DRAM investment accelerates. Advantest remains top pick after raising guidance.
Ascelia Pharma shares surge 8.2% after FDA setback on Orviglance
Swedish biotech advances despite Complete Response Letter on lead MRI contrast agent; cash runway extended into Q2 2027 after cost cuts.
Nanoform cuts Q2 2026 cash burn to EUR 1.5m as regulatory progress accelerates
Finnish drugmaker trims first-half spending by 33% year-on-year while securing $1m deal and advancing nanoenzalutamide toward market authorization.
Clavister posts 63% sales growth, record 30% EBITDA margin in Q2 2026
Swedish cybersecurity firm Clavister reported a 63% year-over-year surge in net sales to 89.2 million Swedish kronor, alongside a record 30% adjusted EBITDA margin. Defence segment revenue surged 370% to 47 million kronor.
Gubra reports H1 2026 profit rebound, obesity pipeline progress
Danish biotech firm returns to profit in H1 2026 as CRO arm grows, while obesity pipeline advances with Phase 2 milestones and new drug candidates.
China warns U.S. against Iran sanctions escalation after Trump threat
Beijing cautions Washington that further sanctions on Tehran would undermine diplomatic solutions, as Trump threatens a 'trade war' over Iran's nuclear program.
Switzerland secures gas supply option via France-Italy pipeline
Bund and gas industry arrange fallback gas access for winter 2026-27. Option covers about 10% of projected winter demand. Costs capped at low single-digit millions, shared across all gas users.
Swiss ETF savings plans surge 44.6% in H1 2026, led by global index funds
Broadly diversified world ETFs dominate Swiss savings plans despite AI and ESG hype, with monthly volume up 29% in Europe. Swiss adoption remains low at 9% of investors.
Accent Group posts A$13.8m loss, unveils FY2026 strategic reset
Australian footwear retailer Accent Group reported a statutory net loss of A$13.8m for FY2026 while outlining a multi-year portfolio overhaul targeting A$40m in cost savings and A$14m EBIT lift by 2030.
HKEX posts record profit on 19% revenue rise in first half of 2026
Hong Kong Exchanges and Clearing reported HK$16.7 billion in revenue and HK$10.6 billion in net profit for the first half of 2026, driven by strong trading volumes and derivatives activity. Interim dividend increased 24% to HK$7.43 per share.
Karnov shares surge 12.86% on Q2 2026 results, AI-driven margin gains
Karnov Group reported a 25% adjusted EBITA margin in Q2 2026, up from 23%, as its AI workflow launch boosted profitability. Shares jumped 12.86% in pre-market trading on the news.
Höegh Autoliners Q2 2026 profit falls 17% as fuel costs surge
Car carrier operator posts $86 million net profit despite 2.6% volume growth and $22 million fuel cost hit. Shares drop 12.6% after results.
Lombard Odier posts 25% profit rise, record assets under management
Swiss private bank reports 9% revenue growth to CHF 740 million in H1 2026, with client assets hitting CHF 239 billion. CET1 capital ratio at 31% exceeds regulatory minimum.
Scatec Q2 2026 results: Obelisk project offsets revenue decline
Renewable energy developer reports 10% drop in EBITDA but cites Africa's largest hybrid project as key offset to flat revenues. Power production rises 21% year-over-year.
Nscale plans $3 bln US IPO as AI data center demand surges
London-based AI data center firm Nscale targets September listing to raise up to $3 billion, citing $51 bln in contracted revenue and 10 GW of planned power capacity.
HKEX posts record H1 2026 profit on trading surge, dividend hike
Hong Kong Exchanges and Clearing reported a 24% rise in H1 2026 profit as trading volumes hit records, with EPS beating estimates by 18%. First interim dividend raised to HKD 7.43 per share.
U.S. debt tops $40 trillion as Fed minutes, Iran tensions lift markets
Fed minutes show dissent on rates as U.S. debt surpasses $40 trillion; Brent crude rises on geopolitical risks while Walmart's ad unit growth supports retail shares.
Karnov Group shares surge 12.9% on AI workflow rollout, Q2 profit beats
Swedish legal data provider Karnov Group posted a 2.4% organic sales increase in Q2 2026, with adjusted EBITA margin rising to 25% as its AI-driven workflow solution drove customer upgrades. Shares jumped 12.9% following the release.
U.S. stocks face midterm election jitters as 2018, 2022 patterns resurface
Historical midterm election years show S&P 500 volatility in late summer and fall, with sector rotations offering clues for 2026. RBC Capital Markets expects contained pullbacks unless recession or rate risks escalate.
Novonesis shares surge 9% after Q2 results, higher 2026 guidance and €1bn buyback
Danish biosolutions firm posts 9% organic sales growth in Q2, beats estimates, raises 2026 outlook and launches inaugural €1bn share repurchase program.
Panoro Energy shares drop 4% after H1 2026 update, CI-27 deal details emerge
Panoro Energy’s stock fell 4% in pre-market trading after releasing H1 2026 pro forma figures and confirming a $80 million acquisition in Ivory Coast. The CI-27 deal, funded via shares and debt, is expected to close by Q3.
Poland’s industrial output rises 5.1% in July, below forecasts
Factory production growth slowed to 5.1% year-on-year in July, undershooting expectations of a 4.9% gain, as mining and manufacturing momentum eased from June.
Options trader bets $2 million on XRP volatility by Aug. 28
A large straddle position on XRP indicates expectations of significant price movement before the August expiration.
Zelluna shares fall 3.6% after Q2 2026 clinical update
Norway-based biotech’s stock declines after first patient dosed in ZIMA-101 trial; cash runway extends into Q3 2027. CEO cites ‘defining’ quarter as trial advances.